Reliance Chemotex Intrinsic Value
Reliance Chemotex (RELCHEMQ) median intrinsic value is ₹165.40 from 8 valuation models (range ₹45–₹246), vs current price ₹122.87 — +34.6% upside (Trading Below Calculated Value), margin of safety 25.7%. For current market price and key ratios, visit Reliance Chemotex screener.
RELCHEMQ Valuation Methods Summary — DCF, Graham Number & P/E
Reliance Chemotex intrinsic value across 8 models vs current price ₹122.87 — upside/downside and value range per method. Also explore RELCHEMQ price movement history to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹85.20 | ₹68.16 - ₹102.24 | -30.7% | EPS: ₹7.10, Sector P/E: 12x |
| Book Value Method | asset | ₹171.25 | ₹154.12 - ₹188.38 | +39.4% | Book Value/Share: ₹171.25, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹245.74 | ₹221.17 - ₹270.31 | +100.0% | Revenue/Share: ₹448.75, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹245.74 | ₹221.17 - ₹270.31 | +100.0% | EBITDA: ₹46.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹127.65 | ₹102.12 - ₹153.18 | +3.9% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹45.44 | ₹40.90 - ₹49.98 | -63.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹56.80 | ₹51.12 - ₹62.48 | -53.8% | Revenue Growth: -0.6%, Adj P/E: 8.0x |
| Graham Defensive Method | conservative | ₹165.40 | ₹148.86 - ₹181.94 | +34.6% | EPS: ₹7.10, BVPS: ₹171.25 |
RELCHEMQ Intrinsic Value vs Market Price — All Valuation Models
Reliance Chemotex fair value range ₹45–₹246 vs current market price ₹122.87 across 8 valuation models. Browse Reliance Chemotex financial data for revenue, profit, balance sheet and cash flow data.
RELCHEMQ Intrinsic Value Analysis — Undervalued or Overvalued?
Reliance Chemotex median intrinsic value ₹165.40, current price ₹122.87 — Trading Below Calculated Value by 34.6%, margin of safety 25.7%.
What is the intrinsic value of RELCHEMQ?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Reliance Chemotex (RELCHEMQ) is ₹165.40 (median value). With the current market price of ₹122.87, this represents a +34.6% variance from our estimated fair value.
The valuation range spans from ₹45.44 to ₹245.74, indicating ₹45.44 - ₹245.74.
Is RELCHEMQ undervalued or overvalued?
Based on our multi-method analysis, Reliance Chemotex (RELCHEMQ) appears to be trading below calculated value by approximately 34.6%.
RELCHEMQ Financial Health — Key Ratios vs Industry Benchmarks
Reliance Chemotex financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.91 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 3.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 12.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.76x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
RELCHEMQ Cash Flow Quality — Operating & Free Cash Flow
Reliance Chemotex operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹11 Cr | ₹11 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹18 Cr | ₹-23 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹0 Cr | ₹-26 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹59 Cr | ₹22 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹27 Cr | ₹6 Cr | Positive Free Cash Flow | 7/10 |